2015 American Transplant Congress

May 2-6, 2015 in Philadelphia, Pennsylvania

View by Title View Sessions

View by Date

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Age-Specific Graft Failure Rates in Pediatric Liver Transplant Recipients

B. Foster,¹ M. Dahhou,¹ X. Zhang,¹ V. Dharnidharka,² J. Conway,³ V. Ng.⁴
Age, Race and Socioeconomic Factors Have a Strong Influence on Candidates Finding a Living Donor Kidney

G. Vranic, A. Nishio Lucar, D. Keith.
Aging Enhances Immunosuppressives Capacities of Tacrolimus By Functional Changes of CD4+ T-Cells

F. Krenzien,¹ M. Quante,¹ A. ElKhal,¹ H. Uehara,¹ R. Abdi,² B. Slegtenhorst,¹ H. Biefer,¹ S. Tullius.¹
ALDH Expression in Facilitating Cells Plays a Critical Role in Regulatory T Cell Induction and GVHD Prevention

H. Xu,¹ T. Miller,¹ Y. Huang,¹ S. Ildstad.^1,2
Aldosterone Acts Directly On T Cells, and Promotes Production of Inflammatory Cytokines

J. Bagley, S. Begum, J. Iacomini.
Alemtuzumab Dose Adjusted for Weight Reduces Infection Post-Renal Transplantation

C.-H. Yoon, M. Willicombe, C. Jogia, R. Charif, J. Galliford, A. McLean, D. Taube.
Alemtuzumab in Elderly Renal Transplant Recipients Is Not Associated With a Poor Outcome

D.-A. Moutzouris, L. Koizia, M. Willicombe, R. Corbett, N. Duncan, J. Galliford, A. McLean, D. Taube.
Alemtuzumab Induction Has Been Safe in the United Kingdom and Achieves Long-Term Steroid Avoidance in More Than 80% of Low Risk Renal Transplant Recipients

A. Seitz,¹ M. Robb,³ S. Balasubramanian,¹ A. McLean,² D. Taube,² R. Johnson,³ R. Baker.¹
Alemtuzumab Induction Is Associated With a Lower Risk of Early Rehospitalization After Kidney Transplant

G. Dube,¹ D. Tsapepas,² Y. Coppleson,³ L. Ratner,⁴ D. Cohen,¹ S. Mohan.¹
Alemtuzumab Induction Is Associated With Higher Risk of Polyomavirrus Associated Nephropathy (PVAN) in Kidney Transplant Recipients

H. Wadei,¹ H. Saull,² C. Enderby,² M. Mai,¹ M. Prendergast,¹ T. Gonwa.¹

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z